StockNews.AI
LH
StockNews.AI
130 days

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

1. Genetic screening market is rapidly growing, driven by technological advancements. 2. Increased consumer interest in personalized medicine boosts demand for genetic tests. 3. Next-generation sequencing (NGS) technology improves accuracy and accessibility of tests. 4. North America leads the market due to strong healthcare infrastructure and awareness. 5. Key players include Labcorp Genetics Inc. and Myriad Genetics, impacting LH.

10m saved
Insight
Article

FAQ

Why Bullish?

The rapid growth in genetic testing markets, particularly in preventive health, indicates strong demand for services that Labcorp Genetics Inc. provides, which could enhance LH's revenue and market position, similar to past growth spurts observed after major technological advancements in the industry.

How important is it?

The article discusses a growing segment that is directly relevant to LH's operations. As the market expands, LH is positioned to capitalize on this trend, thereby influencing its stock price positively.

Why Long Term?

With ongoing technological advancements and increasing consumer awareness, LH is position to benefit from sustained demand in genetic screening for years, as seen in previous market trends where companies that adapted early reaped long-term benefits.

Related Companies

EXASMYGNDGX
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The market for genetic screening testing in preventive health has been experiencing rapid growth, driven by driving factors such as technological advancements, increased consumer interest in personalized medicine, and the rise of preventive healthcare strategies.Several key factors influence the expansion of the genetic screening testing for preventive health market. Improvements in genetic testing technologies, such as next-generation sequencing (NGS), have made these tests more accessible, cost-effective, and accurate. Growing consumer awareness of the benefits of early detection, rising healthcare costs, and an increasing focus on prevention have further fuelled the demand.Moreover, the increasing availability of direct-to-consumer genetic tests has allowed individuals to manage their health. Stakeholders in this market include genetic testing companies, healthcare providers, hospitals, diagnostic laboratories, and wellness-focused organizations. As more people seek personalized, data-driven approaches to healthcare, the demand for genetic screenings as a preventive tool is expected to increase. Moreover, the growing availability of direct-to-consumer genetic testing kits has empowered individuals to take charge of their health and gain insights into their genetic predispositions without necessarily needing a healthcare provider. This trend has significantly expanded the genetic screening market, allowing consumers to access preventive health information more easily.The genetic screening testing for preventive health market is set to witness substantial growth. With continued technological advancements and growing public interest in health optimization and disease prevention, the market offers significant opportunities for healthcare, biotechnology, and wellness stakeholders to meet the rising demand for personalized, proactive health solutions. The development of next-generation sequencing (NGS) technologies and improvements in bioinformatics have made genetic testing more accurate, efficient, and affordable. These innovations allow for comprehensive genetic analysis, enhancing the ability to detect predispositions to various diseases at earlier stages. The continuous evolution of these technologies further drives the demand for genetic screening services in preventive healthcare.Furthermore, there is a growing recognition of the importance of preventive healthcare, with more individuals understanding the benefits of early disease detection and management. Public health campaigns, medical professionals, and organizations have been emphasizing the value of genetic screening to detect health risks before symptoms appear, further driving market demand. Competition and Regional Market AnalysisKey players in the market are Exact Science, Labcorp Genetics Inc., Blueprint Genetics, Ambry Genetics, Genex Diagnostics Inc., Sonic Healthcare, Dante Labs US, Myriad Genetics, Inc., Revvity, Laboratory Corporation of America Holdings, BGI Group, and Fulgent Genetics. North America holds the largest share in the genetic screening testing for preventive health market, primarily driven by technological advancements, robust healthcare infrastructure, and high consumer awareness. The U.S., in particular, is a key player due to its well-established healthcare system, extensive research on genetic testing, and a growing focus on personalized medicine. Additionally, the availability of direct-to-consumer genetic testing companies, such as 23andMe, has increased market penetration. Europe is also a major market for genetic screening, with countries like the United Kingdom, Germany, and France investing heavily in preventive healthcare. The European market is characterized by a high demand for genetic tests related to cancer, cardiovascular diseases, and neurological conditions. The region benefits from strong healthcare policies that encourage genetic testing. The Asia-Pacific region has been experiencing significant growth in the genetic screening testing for preventive health market, driven by increasing healthcare awareness, rising incomes, and growing investment in healthcare infrastructure. Countries such as China, India, Japan, and South Korea are emerging as key markets for genetic testing. While India and China have large populations with diverse genetic profiles, Japan and South Korea are leading the way in terms of advanced healthcare technologies. The Middle East and Africa region presents emerging opportunities for genetic screening, with growing interest in healthcare advancements and genetic testing. The UAE, Saudi Arabia, and South Africa are leading the region's adoption of preventive health measures, including genetic screenings, although economic and infrastructure barriers persist in some areas. Key Topics Covered1. Global Genetic Screening Testing for Preventive Health Market Overview1.1 Market Outlook1.1.1 Definitions1.1.2 Inclusion and Exclusion Criteria1.1.3 Market Size, 2024-2035 (US$)1.1.4 Market Growth Scenario1.1.4.1 Realistic Scenario1.1.4.2 Optimistic Scenario1.1.4.3 Pessimistic Scenario1.2 Industry Outlook1.2.1 Market Overview1.2.2 Market Ecosystem1.2.3 Key Trends1.2.4 Opportunity Assessment1.2.5 Regulatory Landscape1.2.6 Reimbursement Scenario1.3 Market Dynamics1.3.1 Market Opportunities and Trends1.3.2 Market Drivers1.3.2.1 Impact Analysis1.3.3 Market Restraints1.3.3.1 Impact Analysis1.3.4 Market Challenges1.3.4.1 Impact Analysis2. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Test Type2.1 Presymptomatic and Predictive testing2.2 Carrier Screening Test2.2.1 Expanded Carrier Screening2.2.2 Targeted Carrier Screening2.3 Non-Invasive Prenatal Test2.4 Preimplantation Genetic Testing (PGT)2.5 Newborn Screening3. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Technology 3.1 Next Generation Sequencing (NGS)3.2 Microarray3.3 FISH3.4 PCR3.5 Others4. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Application4.1 Oncology4.2 Cardiovascular Disease4.3 Reproductive Health4.4 Neurodegenerative diseases4.5 Rare Disease4.6 Others5. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by End User5.1 Hospitals5.2 Clinics5.3 Direct to Consumer (DTC)5.4 Others6. Global Genetic Screening Testing for Preventive Health Market Analysis in Size (US$) by Geography6.1 Market Overview6.1.1 Market Dynamics6.1.2 Market Size and Forecast6.1.2.1 North America Genetic Screening Testing for Preventive Health Market6.1.2.2 Europe Genetic Screening Testing for Preventive Health Market6.1.2.3 Asia Pacific Genetic Screening Testing for Preventive Health Market6.1.2.4 Latin America Genetic Screening Testing for Preventive Health Market6.1.2.5 Middle East and Africa Genetic Screening Testing for Preventive Health Market7. Global Genetic Screening Testing for Preventive Health Market - Competitive Benchmarking and Company Profiles 7.1 Competitive Benchmarking7.2 Competitive Landscape7.2.1 Key Strategies and Developments by Company7.2.1.1 Funding Activities7.2.1.2 Mergers and Acquisitions7.2.1.3 Regulatory Approvals7.2.1.4 Partnerships, Collaborations, and Business Expansions7.2.2 Key Developments Analysis7.3 Company Profiles7.3.1 Exact Science7.3.1.1 Company Overview7.3.1.2 Product Portfolio/Offering7.3.1.3 Key Competitors7.3.1.4 Target Customers/End Users7.3.1.5 Analyst View7.3.2 Labcorp Genetics Inc.7.3.3 Blueprint Genetics7.3.4 Ambry Genetics7.3.5 Genex Diagnostics Inc.7.3.6 Sonic Healthcare7.3.7 Dante Labs US7.3.8 Myriad Genetics, Inc.7.3.9 Revvity7.3.10 Laboratory Corporation of America Holdings7.3.11 23andMe7.3.12 BGI Group7.3.13 CENTOGENE N.V.7.3.14 Fulgent Genetics.7.3.15 Quest Diagnostics Incorporated.7.3.16 Progenesis7.3.17 CooperSurgical7.3.18 Illumina7.3.19 Igenomix7.3.20 Agilent Technologies, Inc.7.3.21 Other Key CompaniesFor more information about this report visit https://www.researchandmarkets.com/r/nko1zx About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Related News